Back
Speaker illustration

Doctor Julian Gillmore

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)

Julian Gillmore gained his medical degree at University of London and was appointed Professor of Medicine at University College London in 2017. He trained in nephrology and undertook MD and PhD degrees in the field of amyloidosis. His research interests include pathogenesis, diagnosis and treatment of amyloidosis. He was appointed Centre Head at UCL’s Centre for Amyloidosis & Acute Phase Proteins in 2019 and is clinical lead for ATTR amyloidosis at the UK National Amyloidosis Centre. He has published more than 250 peer-reviewed articles, has supervised a number of students through their post-doctoral research degrees, and has received extensive grant funding.

Sessions Presentations Events Articles

A new generation of CRISPR investigational treatments: getting to the heart of the matter

Event: ESC Congress 2024

Topic: Gene Therapy, Cell Therapy

Session type: Satellite Symposium

Access
Thumbnail

The bigger picture: an expert assessment on the true impact of ATTR-cardiomyopathy

Event: ESC Congress 2024

Topic: Cardiac Amyloidosis

Session type: Satellite Symposium

Access
Thumbnail

The advancing management of transthyretin amyloidosis: a practical guide

Event: ESC Congress 2023

Topic: Cardiac Amyloidosis

Session type: Satellite Symposium

Access
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources